SM
IOVA icon

Sabby Management’s Iovance Biotherapeutics IOVA Stock Holding History

Sabby Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-71,251
Closed -$524K – 190
2017
Q2 		$524K Buy
71,251
+11,095
+18% +$70.5K 0.03% 137
2017
Q1 		$448K Sell
60,156
-165,925
-73% -$1.22M 0.02% 184
2016
Q4 		$1.57M Sell
226,081
-20,261
-8% -$139K 0.09% 122
2016
Q3 		$2.03M Sell
246,342
-120,900
-33% -$1.02M 0.08% 131
2016
Q2 		$2.98M Sell
367,242
-45,004
-11% -$283K 0.16% 80
2016
Q1 		$2.09M Buy
412,246
+142,246
+53% +$778K 0.1% 95
2015
Q4 		$2.08M Sell
270,000
-291,894
-52% -$2.03M 0.11% 118
2015
Q3 		$3.24M Buy
561,894
+134,650
+32% +$1.05M 0.13% 117
2015
Q2 		$3.92M Buy
427,244
+52,010
+14% +$580K 0.14% 112
2015
Q1 		$4.54M Buy
+375,234
New +$4.23M 0.19% 85

Other funds holding IOVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return